# New Alcoholism clinical trials: 193 posted since Nov 2024

Updated November 9, 2026.

193 clinical studies in alcoholism were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 13 have an industry sponsor and 153 are recruiting or about to. The newest, NCT07925281, was posted on November 9, 2026: Emotional Reactivity in Severe Alcohol Use Disorder and Major Depressive Disorder Using Eye-tracking... (Université Catholique de Louvain).

## The full list

New Alcoholism clinical trials: 193 rows for $9.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 6 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/alcoholism

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 193
- Industry sponsored: 13
- Recruiting or not yet: 153
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 193, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925281 | Emotional Reactivity in Severe Alcohol Use Disorder and Major Depressive Disorder Using Eye-tracking, Physiological, and Interoceptive... | Université Catholique de Louvain | Observational | Recruiting | Alcohol Use Disorder, Major Depressive Disorder (MDD) | 280 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925281) |
| November 6, 2026 | NCT07922590 | A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation | Medical University of South Carolina | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD), Suicide Ideation | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922590) |
| November 5, 2026 | NCT07920601 | Effects of C-Tactile-optimal Touch on Alcohol Craving and Relapse-Related Biomarkers in Alcohol Use Disorder | Aalto University | Not applicable | Completed | Alcohol Use Disorder | 21 | Finland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920601) |
| November 3, 2026 | NCT07913542 | N-Acetylcysteine for Bipolar and Alcohol Use Disorders | Medical University of South Carolina | Phase 2 | Not yet recruiting | Bipolar Disorder, Alcohol Use Disorder | 70 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913542) |
| November 2, 2026 | NCT07911345 | Connecting Online Military Personnel to Alcohol Harm-reducing Smartphone Support Study | University of New Mexico | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD) | 150 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911345) |
| October 29, 2026 | NCT07902635 | Investigation of the Gut-Brain Axis in Alcohol Use Disorder | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD), Alcohol Abstinence | 78 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902635) |
| October 15, 2026 | NCT07875361 | Disease Intervention Specialist (DIS) for SUD | Ohio State University | Observational | Not yet recruiting | Substance Use Disorder (SUD), Opioid Use Disorder, Alcohol Use Disorder (AUD), Drug Use, Overdose | 1,200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875361) |
| October 14, 2026 | NCT07873944 | Recovery Management Checkup Scalability and Sustainability Hybrid Experiment | Chestnut Health Systems | Phase 3 | Not yet recruiting | Substance Use Disorder (SUD), Opioid Use Disorders, Stimulant Overdose, Overdose Risk, Alcohol Use Disorder | 600 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873944) |
| October 9, 2026 | NCT07868055 | Self-administered Neurostimulation Intervention for Firefighter Traumatic Stress to Reduce Alcohol Use: Pilot Study | University of Cincinnati | Not applicable | Not yet recruiting | Posttraumatic Stress Symptoms, Heavy Alcoholic Consumption, Alcohol Use Disorder (AUD) | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868055) |
| October 5, 2026 | NCT07858513 | Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST ) | Agenzia di Tutela della Salute della Città Metropolitana di Milano | Not applicable | Active not recruiting | Well Being, Drug Addiction, Tobacco Use, Alcohol Abuse, Life Skills, Violence, Bullying, Health Literacy | 3,927 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858513) |
| September 28, 2026 | NCT07844720 | Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 | Recruiting | Alcohol Use Disorder | 60 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844720) |
| September 25, 2026 | NCT07842588 | Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic... | Mark J Rzeszutek, PhD | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD), Suicidal Ideation | 180 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842588) |
| September 24, 2026 | NCT07839026 | Greek Connections Study | University of Washington | Not applicable | Recruiting | Heavy Episodic Drinking, Problem Drinking, College Student Drinking | 480 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839026) |
| September 17, 2026 | NCT07825818 | Imaging Mitochondrial Complex-I in Alcohol Use Disorder | Rajesh Narendran | Early phase 1 | Recruiting | Alcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825818) |
| September 17, 2026 | NCT07824089 | Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism | The Cleveland Clinic | Not applicable | Recruiting | Alcohol Use Disorder (AUD), Alcohol Related Liver Disease | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824089) |
| September 9, 2026 | NCT07810946 | Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients | University of Colorado, Denver | Phase 1/2 | Not yet recruiting | Alcohol Withdrawal, Alcohol Abstinence, Alcohol Use Disorder | 75 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810946) |
| September 8, 2026 | NCT07808190 | HD-tACS for Alcohol Use Disorder | Shanghai Mental Health Center | Not applicable | Not yet recruiting | Alcohol Use Disorder | 140 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808190) |
| August 26, 2026 | NCT07788716 | Sensory and Physical Reactions to Beverage Cues | University of Texas Southwestern Medical Center | Not applicable | Recruiting | Alcohol Use Disorder (AUD) | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788716) |
| August 19, 2026 | NCT07772960 | Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes | Yale University | Phase 1 | Recruiting | Alcohol Use Disorder (AUD), Obesity (BMI Equal to or \>30) | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772960) |
| August 18, 2026 | NCT07769580 | Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior | Emory University | Not applicable | Not yet recruiting | HIV, Risk Behavior, Alcohol Abuse | 240 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769580) |
| August 10, 2026 | NCT07755046 | Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder | Ting-Gang Chang | Not applicable | Completed | Alcohol Use Disorder (AUD), Alcoholism | 9 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755046) |
| August 5, 2026 | NCT07748078 | Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia | The Jerzy Kukuczka Academy of Physical Education in Katowice | Not applicable | Not yet recruiting | SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder, Alcohol Dependence (Primary Condition) | 140 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748078) |
| August 4, 2026 | NCT07746154 | Alpha Down Electroencephalography (EEG) Neurofeedback for Alcohol Use Disorder: Feasibility Trial | Brigham and Women's Hospital | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD) | 10 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746154) |
| July 30, 2026 | NCT07735585 | TRIS: Contingency Management App for Alcohol Use Disorder | University of Sao Paulo General Hospital | Not applicable | Recruiting | Alcohol Use Disorder (AUD) | 130 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07735585) |
| July 29, 2026 | NCT07734701 | Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder | Sherwood Brown, MD, PhD | Phase 2 | Not yet recruiting | Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD) | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734701) |
| July 27, 2026 | NCT07728968 | The 15-Mental Project: Implementation and Evaluation of the 15-Mental in a Mental Health Hospital Setting | University of Southern Denmark | Not applicable | Active not recruiting | Dual Diagnosis, Alcohol Use Disorder, Hazardous Alcohol Use, Screening and Brief Intervention | 14 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728968) |
| July 24, 2026 | NCT07724275 | Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services | Brandeis University | Not applicable | Recruiting | Alcohol Use Disorder, Recovery Outcomes, Digital Health | 65 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724275) |
| July 20, 2026 | NCT07713251 | Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training | Brown University | Not applicable | Recruiting | Alcohol Use Disorder | 112 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713251) |
| July 20, 2026 | NCT07712796 | Empowerment Self Defense Program for Adult Native Women Survivors of Sexual Violence | University of Michigan | Not applicable | Not yet recruiting | Depression and Quality of Life, Sexual Violence, PTSD, Suicidal Ideation, Problem Drinking | 14 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712796) |
| July 16, 2026 | NCT07706660 | Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL) | Medical University of Warsaw | Not applicable | Recruiting | Alcohol Use Disorder (AUD), Alcohol-Related Disorders | 240 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706660) |
| July 14, 2026 | NCT07701928 | Daridorexant for People With Insomnia and Alcohol Use Disorder Study | Sterling McPherson | Phase 2 | Not yet recruiting | Alcohol Use Disorder, Insomnia | 205 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07701928) |
| July 9, 2026 | NCT07692984 | The Effect of Comorbid Alcohol/Substance Use | Abant Izzet Baysal University | Observational | Recruiting | Alcohol Abuse, Alcohol Use Disorder, Substance Use Disorders, Severe Mental Disorder, Schizophrenia, Bipolar Disorder... | 297 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692984) |
| July 8, 2026 | NCT07690423 | Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal | Centre Hospitalier Esquirol | Not applicable | Not yet recruiting | Cognitive Cycling, Alcohol Use Disorder (AUD), Treatment | 128 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690423) |
| July 2, 2026 | NCT07681869 | Effects of Nimodipine on Alcohol Drinking | Yale University | Phase 2 | Not yet recruiting | Alcohol Use Disorder | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681869) |
| July 1, 2026 | NCT07678567 | Pomegranate Dietary Supplements in AUD and ALD | University of Louisville | Observational | Not yet recruiting | Alcohol Use Disorder, Alcohol-associated Liver Disease, Alcoholic Cirrhosis, Healthy | 144 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07678567) |
| June 30, 2026 | NCT07677449 | Preventing Harmful Alcohol Use Among Trauma Patients in Cameroon | University of Buea | Not applicable | Not yet recruiting | Alcohol Use Disorder, Alcohol-Related Injury, Trauma | 690 | Cameroon | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07677449) |
| June 25, 2026 | NCT07667790 | Effects of Olfactory Stimuli in Virtual Reality Cue Exposure on Craving and Attentional Bias in Alcohol Use Disorder | Charite University, Berlin, Germany | Not applicable | Not yet recruiting | Alcohol Use Disorder | 60 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667790) |
| June 22, 2026 | NCT07661823 | QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos.... | Veterans Recovery Network Inc. | Not applicable | Not yet recruiting | Asperger's Disorder, Asperger Disorder, Autism Disorder, Autism, ADHD - Attention Deficit Disorder With Hyperactivity... | 1,000,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661823) |
| June 10, 2026 | NCT07638553 | Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms | Centre Hospitalier Universitaire de Nīmes | Phase 3 | Recruiting | Alcohol Use Disorder, Depressive Sympotoms, Psilocybin | 172 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638553) |
| June 9, 2026 | NCT07637539 | Elastography-based Brief Alcohol Intervention in Hospitalized Individuals | Oslo University Hospital | Not applicable | Recruiting | Alcoholic Liver Disease (ALD), Alcohol Use Disorder | 500 | Norway | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07637539) |
| June 5, 2026 | NCT07630012 | High Intensity Use of Urgent and Emergency Care: A Mixed-Methods Study | Bournemouth University | Observational | Not yet recruiting | High Intensity Use of Urgent and Emergency Care, Emergency Medicine, Health Inequalities, Mental Health, Alcohol Use... | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630012) |
| May 29, 2026 | NCT07612631 | Imaging CRF X NOP Interactions in Alcohol Use Disorder | Rajesh Narendran | Early phase 1 | Recruiting | Alcohol Use Disorder | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612631) |
| May 22, 2026 | NCT07603726 | Multimodal Intervention for GGT Reduction in Alcohol Use Disorder (GGT-AUD) | Medical Center TOPMED | Not applicable | Completed | Alcohol Use Disorder (AUD) | 197 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07603726) |
| May 22, 2026 | NCT07602270 | Effects of Ketogenic Diet on Alcohol Intoxication | University of Pennsylvania | Not applicable | Recruiting | Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder, Magnetic Resonance Imaging, Alcohol Intoxication | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602270) |
| May 18, 2026 | NCT07593664 | Evaluation of a Virtual Reality-based Version of the Multiple Errands Test in Alcohol Use Disorder | Hôpital le Vinatier | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD) | 90 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593664) |
| May 13, 2026 | NCT07582692 | Sequential Prefrontal Alpha-Theta Neurofeedback on Abstinence Self-Efficacy, Mindfulness, and EEG in Alcohol Use Disorder | Seoul University of Buddhism | Not applicable | Completed | Alcohol Use Disorder | 17 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582692) |
| May 12, 2026 | NCT07580378 | Exploration of Acceptability of Alcohol Interventions | East Lancashire Hospitals NHS Trust | Observational | Not yet recruiting | Alcohol Misuse, Alcohol Use Disorder, Behaviour Change, Health Behaviour, Brief Intervention, Outcome Assessment... | 2,000 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580378) |
| May 7, 2026 | NCT07573540 | Optimizing Smart Technology for Addiction Recovery | University of Wisconsin, Madison | Not applicable | Recruiting | Alcohol Use Disorder, Alcohol Use Disorder (AUD) | 416 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07573540) |
| May 6, 2026 | NCT07571226 | Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness | Huashan Hospital | Observational | Recruiting | Major Depressive Disorder (MDD), Anxiety Disorder, Alcohol Use Disorder (AUD) | 680 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571226) |
| May 1, 2026 | NCT07561749 | SER-ABS-AUD: Neuropsychosocial-Spiritual Correlates of Serene Abstinence in Adults With AUD | Grigore T. Popa University of Medicine and Pharmacy | Observational | Enrolling by invitation | Alcohol Use Disorder (AUD), Alcohol Abstinence | 70 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561749) |
| April 30, 2026 | NCT07559500 | Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 1 | Recruiting | Alcohol Use Disorder (AUD) | 176 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559500) |
| April 28, 2026 | NCT07553377 | A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease | Yale University | Not applicable | Not yet recruiting | Alcohol Use Disorder, Alcohol Associated Liver Disease, Medications for Alcohol Use Disorder, Behavioral Medicine... | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553377) |
| April 27, 2026 | NCT07551830 | Process-Based Psychological Processes in Alcohol Use Disorder: A Case-Control Study Using PBAT, PHQ-9, and GAD-7 | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Observational | Not yet recruiting | Alcohol Use Disorder (AUD) | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551830) |
| April 15, 2026 | NCT07532252 | Daridorexant for Alcohol Use Disorder | Johns Hopkins University | Phase 2 | Not yet recruiting | Alcohol Use Disorder | 150 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532252) |
| April 13, 2026 | NCT07525271 | Trial Phase: Syndemic Adapted Medly Uganda | Yale University | Not applicable | Recruiting | Mental Health | 1,500 | Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525271) |
| April 13, 2026 | NCT07525258 | Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD) | Yale University | Not applicable | Recruiting | Alcohol Use Disorder, Alcohol-associated Liver Disease | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525258) |
| April 9, 2026 | NCT07520292 | Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder | Newleos Therapeutics, Inc. | Phase 1 | Recruiting | Alcohol Use Disorder | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520292) |
| April 3, 2026 | NCT07510113 | Probiotic Study in Alcohol Recovery | Loughborough University | Not applicable | Completed | Alcohol Use Disorder | 38 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510113) |
| March 31, 2026 | NCT07503782 | OEA for Young Adults With Alcohol Use Disorder | Medical University of South Carolina | Phase 2 | Not yet recruiting | Alcohol Use Disorder (AUD) | 42 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07503782) |
| March 30, 2026 | NCT07501130 | Feasibility of Telephone-based Acceptance and Commitment Therapy in Hong Kong Chinese Young Adults With Alcohol Use Disorder: A Pilot Study | The Hong Kong Polytechnic University | Not applicable | Active not recruiting | Alcohol Use Disorder, Alcohol Abstinence | 60 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501130) |
| March 23, 2026 | NCT07488819 | Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer... | Yale University | Observational | Recruiting | Post-Traumatic Stress Disorder, PTSD, Alcohol Use Disorder (AUD) | 160 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07488819) |
| March 19, 2026 | NCT07482150 | The Connect Trial: Connecting Hospital Patients to Alcohol Care | Zealand University Hospital | Not applicable | Recruiting | Alcohol Use Disorder | 60 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07482150) |
| March 17, 2026 | NCT07475988 | Adapting a Telehealth Intervention for Suicide Prevention Among Patients With Alcohol Use Disorder in Tanzania | Duke University | Not applicable | Not yet recruiting | Alcohol Use Disorder, Suicide Prevention | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475988) |
| March 16, 2026 | NCT07474207 | Social Identity Mapping for Adolescent Recovery | Massachusetts General Hospital | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD) | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474207) |
| March 16, 2026 | NCT07472673 | Transcranial Temporal Interference Stimulation Targeted of the Amygdala as an Intervention for Alcohol Use Disorder Patients | Shanghai Mental Health Center | Not applicable | Not yet recruiting | Alcohol Use Disorder | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472673) |
| March 13, 2026 | NCT07468825 | Influence of Individual Traits on Adaptation Processes in Individuals With Alcohol Use Disorder | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Alcohol Use Disorder, Cognition Disorders | 30 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468825) |
| March 12, 2026 | NCT07465588 | Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease | Massachusetts General Hospital | Not applicable | Not yet recruiting | Alcohol Use Disorder, Alcohol-associated Liver Disease, Liver Cirrhosis, Alcoholic, Alcohol-Associated Hepatitis | 90 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465588) |
| March 11, 2026 | NCT07464613 | Social Cognition in Severe Alcohol Use Disorder | CHU de Reims | Not applicable | Recruiting | Alcohol Use Disorder | 60 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07464613) |
| March 5, 2026 | NCT07452146 | Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use | University of California, Los Angeles | Phase 2 | Not yet recruiting | Alcohol Use Disorder, Inflammatory Response, Craving | 64 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07452146) |
| March 5, 2026 | NCT07451574 | Acceptability and Feasibility Study of Non-alcoholic Beverages | Stanford University | Not applicable | Enrolling by invitation | Alcohol Use Disorder (AUD) | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07451574) |
| February 25, 2026 | NCT07433413 | Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder | Shenzhen Sciencare Medical Industries Co., Ltd. | Phase 3 | Not yet recruiting | Alcohol Use Disorder (AUD) | 240 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07433413) |
| February 24, 2026 | NCT07430787 | Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care | University of Turku | Observational | Active not recruiting | Hyponatremia, Osmotic Demyelination Syndrome, Alcohol Use Disorder | 10,000 | Finland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430787) |
| February 17, 2026 | NCT07413458 | Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD) | University of Michigan | Not applicable | Recruiting | Alcohol Use Disorder | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07413458) |
| February 12, 2026 | NCT07405606 | Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder | Centre for Addiction and Mental Health | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) | 30 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405606) |
| February 9, 2026 | NCT07397598 | Peer Support for Liver Transplant Recipients With History of ALD | Johns Hopkins University | Not applicable | Recruiting | Alcohol Use Disorder, Alcohol Related Liver Disease, Liver Transplant Recipient | 95 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397598) |
| February 5, 2026 | NCT07390877 | Cognitive and Metacognitive Remediation in Addiction Treatment. | Nantes University Hospital | Not applicable | Not yet recruiting | Alcohol Use Disorder | 130 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390877) |
| February 5, 2026 | NCT07388693 | Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence | Charite University, Berlin, Germany | Not applicable | Completed | Alcohol Dependence | 20 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388693) |
| February 5, 2026 | NCT07388654 | PTSD and Alcohol Couples Treatment for Veterans | VA Office of Research and Development | Early phase 1 | Not yet recruiting | PTSD, AUD | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388654) |
| January 28, 2026 | NCT07373405 | Online Interventions to Prevent Alcohol Use Disorders | University of Southern Denmark | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD) | 3,519 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373405) |
| January 27, 2026 | NCT07371286 | Administration of Fiber as a Dietary Supplement to Improve the Management of Alcohol Withdrawal | Assistance Publique - Hôpitaux de Paris | Not applicable | Not yet recruiting | Alcohol Use Disorder, Supplementation, Intestinal Permeability | 138 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07371286) |
| January 27, 2026 | NCT07369245 | Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction | Versailles Hospital | Not applicable | Not yet recruiting | Alcohol Addiction | 98 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07369245) |
| January 15, 2026 | NCT07342504 | Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment | University of Notre Dame | Not applicable | Recruiting | Alcohol Use Disorder, Opioid Use Disorder, Alcohol Use, Opioid Use | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342504) |
| January 14, 2026 | NCT07341230 | Deep Brain Stimulation to Understand and Treat Addiction | University of Cambridge | Not applicable | Recruiting | Alcohol Use Disorder | 9 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341230) |
| January 13, 2026 | NCT07337733 | Brief Contextual-Behavioral vs Twelve-Step Intervention for Emotion Regulation in Substance Use: Pilot Study | Lauro Gutiérrez Castro | Not applicable | Completed | Substance Use Disorders, Drug Use Disorder, Alcohol Use Disorder, Emotional Dysregulation, Distress Intolerance | 36 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07337733) |
| January 8, 2026 | NCT07325266 | Human Laboratory Study of Apremilast for Alcohol Use Disorder | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 | Recruiting | Alcohol Use Disorder, Alcohol Misuse | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325266) |
| December 29, 2025 | NCT07306078 | Methylphenidate and Response to Alcohol Cues | University of Florida | Phase 2 | Not yet recruiting | Alcohol Use Disorder | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07306078) |
| December 26, 2025 | NCT07305701 | Cohort Study on Medical Students' Mental Health | Centre Hospitalier Régional d'Orléans | Observational | Recruiting | Major Depressive Disorder, Generalized Anxiety Disorder, Suicidal Ideation, Alcoholism, Marijuana Abuse, Loneliness | 10,000 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07305701) |
| December 22, 2025 | NCT07296094 | Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Alcohol Use Disorder | 36 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07296094) |
| December 18, 2025 | NCT07292519 | Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) | South West Sydney Local Health District | Phase 2 | Not yet recruiting | Alcohol Use Disorder (AUD), Overweight or Obese, Comorbidities and Coexisting Conditions | 46 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292519) |
| December 15, 2025 | NCT07281261 | tAN for Substance Use Disorder | Spark Biomedical, Inc. | Not applicable | Recruiting | Alcohol Use Disorder, Alcohol Abuse, Substance Use Disorders, Substance Use Disorders Alcohol Use Withdrawal State | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07281261) |
| December 12, 2025 | NCT07279558 | Cannabidiol and Alcohol Use Disorder Phenotypes | University of Colorado, Denver | Phase 2 | Recruiting | Alcohol Use Disorder | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07279558) |
| December 12, 2025 | NCT07279363 | Deaf CBT-TS to Reduce Suicide Risk | University of Rochester | Not applicable | Not yet recruiting | Depression - Major Depressive Disorder, Anxiety, PTSD - Post Traumatic Stress Disorder, Insomnia, Alcohol Use Disorder... | 110 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07279363) |
| December 10, 2025 | NCT07273955 | Alcohol Use Disorder Before and After Bariatric Surgery and the Impact of Considering This Surgery During Addiction Follow-up | University Hospital, Strasbourg, France | Observational | Recruiting | Alcohol Use Disorder | 20 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07273955) |
| December 8, 2025 | NCT07269873 | Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol | BioCorRx Pharmaceuticals Inc | Phase 1 | Recruiting | Healthy Adult Male and Female Volunteers | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269873) |
| December 8, 2025 | NCT07269119 | Piloting a Deaf Accessible Pre-Treatment for AUD | University of Massachusetts, Worcester | Not applicable | Recruiting | Alcohol Use Disorder | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269119) |
| December 3, 2025 | NCT07260149 | Coordinated Care for Alcohol Problems | Sangath | Not applicable | Recruiting | Alcohol Use Disorder | 1,022 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07260149) |
| November 25, 2025 | NCT07249554 | Combination Therapy for Alcohol Use Disorder | Johns Hopkins University | Phase 2 | Not yet recruiting | Alcohol Use Disorder | 45 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249554) |
| November 25, 2025 | NCT07247370 | Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) | South West Sydney Local Health District | Phase 1/2 | Not yet recruiting | Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD), Comorbidities and Coexisting Conditions | 20 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247370) |
| November 18, 2025 | NCT07232641 | Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic | Boston University | Observational | Recruiting | Substance Use Disorders, Alcohol Use Disorder, Opioid Use Disorder | 185,810 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07232641) |
| November 12, 2025 | NCT07227545 | High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study | Shanghai Mental Health Center | Not applicable | Recruiting | Alcohol Use Disorder (AUD) | 18 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227545) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Yale University | 12 | August 19, 2026 |
| Shanghai Mental Health Center | 5 | September 8, 2026 |
| Johns Hopkins University | 4 | April 15, 2026 |
| Medical University of South Carolina | 3 | November 6, 2026 |
| Brigham and Women's Hospital | 3 | August 4, 2026 |
| University of Michigan | 3 | July 20, 2026 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 3 | April 30, 2026 |
| Massachusetts General Hospital | 3 | March 16, 2026 |
| VA Office of Research and Development | 3 | February 5, 2026 |
| Eli Lilly and Company | 3 | October 22, 2025 |
| Washington State University | 3 | September 12, 2025 |
| Ohio State University | 2 | October 15, 2026 |
| University of Washington | 2 | September 24, 2026 |
| Rajesh Narendran | 2 | September 17, 2026 |
| University of Colorado, Denver | 2 | September 9, 2026 |
| University of Southern Denmark | 2 | July 27, 2026 |
| Brown University | 2 | July 20, 2026 |
| Charite University, Berlin, Germany | 2 | June 25, 2026 |
| University of Pennsylvania | 2 | May 22, 2026 |
| The Hong Kong Polytechnic University | 2 | March 30, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 106 | November 6, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 30 | November 9, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 30 | November 3, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 10 | August 19, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 8 | October 14, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 4 | September 17, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 3 | August 29, 2025 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 2 | September 9, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 94 | November 6, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 13 | September 28, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 9 | June 25, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 8 | September 8, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 6 | May 12, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 5 | July 27, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 5 | July 9, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 4 | November 9, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 3 | August 10, 2026 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 3 | May 22, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 3 | May 13, 2026 |
| [Uganda](https://specstream.ai/data/clinical-trials/country/uganda) | 3 | April 13, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 3 | March 30, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 3 | February 12, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 3 | October 15, 2025 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 3 | July 17, 2025 |
| [Finland](https://specstream.ai/data/clinical-trials/country/finland) | 2 | November 5, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 2 | October 29, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 2 | August 5, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 2 | January 13, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 2 | December 18, 2025 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 2 | October 22, 2025 |
| [South Africa](https://specstream.ai/data/clinical-trials/country/south-africa) | 2 | September 2, 2025 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 1 | July 30, 2026 |
| Cameroon | 1 | June 30, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).